{
  "pmid": "23456789",
  "title": "Efficacy of Drug B in Type 2 Diabetes Management",
  "year": 2022,
  "population": {
    "description": "Adults with type 2 diabetes, HbA1c > 7%",
    "sample_size": 520
  },
  "endpoints": [
    {
      "endpoint_phrase": "HbA1c reduction at 24 weeks",
      "point_estimate": -1.2,
      "confidence_interval": {
        "lower": -1.5,
        "upper": -0.9
      },
      "p_value": 0.0001
    },
    {
      "endpoint_phrase": "fasting glucose reduction",
      "point_estimate": -32.0,
      "confidence_interval": {
        "lower": -38.0,
        "upper": -26.0
      },
      "p_value": 0.0005
    },
    {
      "endpoint_phrase": "body weight change",
      "point_estimate": -2.1,
      "confidence_interval": {
        "lower": -3.0,
        "upper": -1.2
      },
      "p_value": 0.01
    }
  ],
  "study_design": "RCT"
}